Related references
Note: Only part of the references are listed.Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes
Eric E. Kaczor et al.
JOURNAL OF MEDICAL TOXICOLOGY (2021)
Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives
Davide Radaelli et al.
CURRENT NEUROPHARMACOLOGY (2021)
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro
Chris Bladen et al.
NEUROPHARMACOLOGY (2021)
MAM-2201, One of the Most Potent-Naphthoyl Indole Derivative-Synthetic Cannabinoids, Exerts Toxic Effects on Human Cell-Based Models of Neurons and Astrocytes
T. Coccini et al.
NEUROTOXICITY RESEARCH (2021)
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
Janet Schloss et al.
FRONTIERS IN ONCOLOGY (2021)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabis Use and the Risk of Psychosis and Affective Disorders
Lucia Sideli et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
Katarina Cerne
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Krista J. Spiller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Cannabis and Psychosis Through the Lens of DSM-5
Nathan T. Pearson et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
US Epidemiology of Cannabis Use and Associated Problems
Deborah S. Hasin
NEUROPSYCHOPHARMACOLOGY (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker et al.
MOLECULAR PHARMACOLOGY (2018)
Strokes are possible complications of cannabinoids use
Valerie Wolff et al.
EPILEPSY & BEHAVIOR (2017)
A 10-year review of cannabis exposure in children under 3-years of age: do we need a more global approach?
Isabelle Claudet et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects
Andrew C. Parrott et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
Cannabis-associated psychosis: Neural substrate and clinical impact
R. M. Murray et al.
NEUROPHARMACOLOGY (2017)
Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed
David E. Mandelbaum et al.
PEDIATRIC NEUROLOGY (2017)
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
Tabea Schoeler et al.
LANCET PSYCHIATRY (2017)
Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study
Simon L. Hill et al.
CLINICAL TOXICOLOGY (2016)
Cannabinoid Control of Learning and Memory through HCN Channels
Mattia Maroso et al.
NEURON (2016)
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Marco Colizzi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY
Alessia Ligresti et al.
PHYSIOLOGICAL REVIEWS (2016)
CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience
Michal Tzadok et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Nora D. Volkow et al.
JAMA PSYCHIATRY (2016)
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center
Kenneth D. Katz et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2016)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Risks Associated With the Non-Medicinal Use of Cannabis
Eva Hoch et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2015)
Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains
Jodi M. Gilman et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date
Musa Basser Sami et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Synthetic Cannabinoid-Related Illnesses and Deaths
Jordan Trecki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Longitudinal changes in white matter microstructure after heavy cannabis use
Mary P. Becker et al.
DEVELOPMENTAL COGNITIVE NEUROSCIENCE (2015)
Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
Valerie Wolff et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Presentations to the Emergency Department Following Cannabis use-a Multi-Centre Case Series from Ten European Countries
Alison M. Dines et al.
JOURNAL OF MEDICAL TOXICOLOGY (2015)
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies
Tiina Rekand
EUROPEAN NEUROLOGY (2014)
Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users
Jodi M. Gilman et al.
JOURNAL OF NEUROSCIENCE (2014)
Effects of cannabis on cognition in patients with MS A psychometric and MRI study
Bennis Pavisian et al.
NEUROLOGY (2014)
Long-Term Effects of Cannabis on Brain Structure
Giovanni Battistella et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Adverse Health Effects of Marijuana Use
Valerie Wolff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Parental Cannabis Abuse and Accidental Intoxications in Children Prevention by Detecting Neglectful Situations and At-Risk Families
Fanny Pelissier et al.
PEDIATRIC EMERGENCY CARE (2014)
Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
Marta Di Forti et al.
SCHIZOPHRENIA BULLETIN (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Acute intoxication by synthetic cannabinoids - Four case reports
Maren Hermanns-Clausen et al.
DRUG TESTING AND ANALYSIS (2013)
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
Antonio Garcia-Merino
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
R. M. Langford et al.
JOURNAL OF NEUROLOGY (2013)
White Matter Integrity as a Link in the Association Between Motivation to Abstain and Treatment Outcome in Adolescent Substance Users
Tammy Chung et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2013)
Spicy Seizure
Sadip Pant et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
Effect of long-term cannabis use on axonal fibre connectivity
Andrew Zalesky et al.
BRAIN (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls
Janna Cousijn et al.
NEUROIMAGE (2012)
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making
Jatin G. Vaidya et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Quantifying the Clinical Significance of Cannabis Withdrawal
David J. Allsop et al.
PLOS ONE (2012)
Persistent cannabis users show neuropsychological decline from childhood to midlife
Madeline H. Meier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Kathryn A. Seely et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection
Hai Chen et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The dual neuroprotective-neurotoxic profile of cannabinoid drugs
Yosef Sarne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Severe Toxicity Following Synthetic Cannabinoid Ingestion
J. Lapoint et al.
CLINICAL TOXICOLOGY (2011)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Why So Impulsive? White Matter Alterations Are Associated With Impulsivity in Chronic Marijuana Smokers
Staci A. Gruber et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2011)
Understanding aberrant white matter development in schizophrenia: an avenue for therapy?
Mark Walterfang et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?
Maria Jose Fernandez-Serrano et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Cerebellar white-matter changes in cannabis users with and without schizophrenia
N. Solowij et al.
PSYCHOLOGICAL MEDICINE (2011)
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Ana Gonzalez-Pinto et al.
SCHIZOPHRENIA BULLETIN (2011)
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light
Alessandra Paparelli et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Beyond THC: the new generation of cannabinoid designer drugs
Liana Fattore et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Cannabinoid and Cannabinoid-Like Receptors in Microglia, Astrocytes, and Astrocytomas
Nephi Stella
GLIA (2010)
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Luciano De Petrocellis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
High-potency cannabis and the risk of psychosis
Marta Di Forti et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death
Domenico E. Pellegrini-Giampietro et al.
FEBS JOURNAL (2009)
Changes in Hippocampal Morphology and Neuroplasticity Induced by Adolescent THC Treatment are Associated With Cognitive Impairment in Adulthood
Tiziana Rubino et al.
HIPPOCAMPUS (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Regional brain abnormalities associated with long-term heavy cannabis use
Murat Yuecel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Adverse effects of medical cannabinoids: a systematic review
Tongtong Wang et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Mechanisms of control of neuron survival by the endocannabinoid system
Ismael Galve-Roperh et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
A role for p53 in the regulation of lysosomal permeability by Δ9-tetrahydrocannabinol in rat cortical neurones:: implications for neurodegeneration
Aoife Gowran et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Endocannabinoids mediate neuron-astrocyte communication
Marta Navarrete et al.
NEURON (2008)
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice
Matilda Degn et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17β-estradiol
Diana Amantea et al.
FEBS JOURNAL (2007)
Automatic and controlled processes and the development of addictive behaviors in adolescents: A review and a model
Reinout W. Wiers et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Miriam Melis et al.
NEUROBIOLOGY OF DISEASE (2006)
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection
Leyre Mestre et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
E Gouzoulis-Mayfrank et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Coma due to cannabis toxicity in an infant
Andrew Appelboam et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2006)
Endocannabinoid signaling in rat somatosensory cortex:: Laminar differences and involvement of specific interneuron types
AL Bodor et al.
JOURNAL OF NEUROSCIENCE (2005)
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia
C Pantelis et al.
SCHIZOPHRENIA BULLETIN (2005)
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells -: Implications for anandamide-induced apoptosis
M Bari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neurocognitive consequences of marihuana - a comparison with pre-drug performance
PA Fried et al.
NEUROTOXICOLOGY AND TERATOLOGY (2005)
A cross-study comparison of cannabis and tobacco withdrawal
RG Vandrey et al.
AMERICAN JOURNAL ON ADDICTIONS (2005)
Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes
JW Huffman et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Diseases of white matter and schizophrenia-like psychosis
M Walterfang et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2005)
Cb-1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons
G Nyiri et al.
NEUROSCIENCE (2005)
The dark side of endocannabinoids: A neurotoxic role for anandamide
I Cernak et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Massive accumulation of N-acylethanolamines after stroke.: Cell signalling in acute cerebral ischemia?
C Berger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids
A Bacci et al.
NATURE (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Are cannabinoid drugs neurotoxic or neuroprotective?
Y Sarne et al.
MEDICAL HYPOTHESES (2004)
Anandamide content is increased and Cb-1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
S Muthian et al.
NEUROSCIENCE (2004)
Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study
G Kanayama et al.
PSYCHOPHARMACOLOGY (2004)
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways
VA Movsesyan et al.
CELL DEATH AND DIFFERENTIATION (2004)
Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons
EJ Downer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis
M Maccarrone et al.
CELL DEATH AND DIFFERENTIATION (2003)
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
A Klegeris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Ceramide is involved in R(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells
R Ramer et al.
MOLECULAR PHARMACOLOGY (2003)
The stimulatory effect of cannabinoids on calcium uptake is mediated by G(s) GTP-binding proteins and CAMP formation
R Bash et al.
NEUROSIGNALS (2003)
Cannabinoids and cell fate
M Guzmán et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum
AC Kreitzer et al.
NEURON (2002)
The cannabinoid agonist DALN dependent calcium-channels positively modulates L-type voltage-in N18TG2 neuroblastoma cells
V Rubovitch et al.
MOLECULAR BRAIN RESEARCH (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment
N Solowij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
D Panikashvili et al.
NATURE (2001)
Marijuana abstinence effects in marijuana smokers maintained in their home environment
AJ Budney et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity
M van der Stelt et al.
JOURNAL OF NEUROSCIENCE (2001)
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus
P Derkinderen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Pharmacology and effects of cannabis: a brief review
CH Ashton
BRITISH JOURNAL OF PSYCHIATRY (2001)
Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2
J Lawston et al.
BRAIN RESEARCH (2000)
Share Paper
